Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Metastatic Castration-Resistant Prostate Cancer × onvansertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration-Resistant Prostate Cancer 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1

Interventions

sapanisertib 1 onvansertib 1 enzalutamide 1 abiraterone 1 abemaciclib 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03414034 2024-11-07

Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer

Cardiff Oncology

Phase 2 Completed

72 enrolled 21 charts

Metastatic Castration-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡